{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:07:41Z","timestamp":1790154461980,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.humimm.2026.112039","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:01:38Z","timestamp":1785848498000},"page":"112039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum sPD-1 and sTIM-3 as T-cell exhaustion biomarkers in systemic lupus erythematosus: The IL-6-associated exhaustion axis and the SLE Immune Exhaustion Index"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5532-7508","authenticated-orcid":false,"given":"Abdullah Salim","family":"Al-Karawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-2178","authenticated-orcid":false,"given":"Ali Saad","family":"Al-Budairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.humimm.2026.112039_bb0005","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2026.112039_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.humimm.2026.112039_bb0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrrheum.2010.60","article-title":"T cells as therapeutic targets in SLE","volume":"6","author":"Crispin","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.humimm.2026.112039_bb0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.humimm.2026.112039_bb0025","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining T cell exhaustion","volume":"19","author":"Blank","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2026.112039_bb0030","article-title":"T cell exhaustion dynamics in systemic autoimmune disease","author":"Wiesner","year":"2023","journal-title":"bioRxiv [Preprint]"},{"key":"10.1016\/j.humimm.2026.112039_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587460","article-title":"Soluble PD-1: predictive, prognostic, and therapeutic value for cancer immunotherapy","volume":"11","author":"Khan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.112039_bb0040","article-title":"The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.112039_bb0045","doi-asserted-by":"crossref","first-page":"34529","DOI":"10.1074\/jbc.M113.488478","article-title":"A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3)","volume":"288","author":"Moller-Hackbarth","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2026.112039_bb0050","article-title":"Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers","volume":"208","author":"Andrews","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.humimm.2026.112039_bb0055","first-page":"872","article-title":"IL-6\/STAT3 signaling axis enhances and prolongs Pdcd1 expression in murine CD8 T cells","volume":"6","author":"Mender","year":"2022","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.humimm.2026.112039_bb0060","first-page":"E2960","article-title":"The dark side of IL-6-mediated STAT3 signaling in tumor immune evasion","volume":"19","author":"Mojic","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.112039_bb0065","article-title":"The effect of baricitinib on pSTAT3 levels in IL-6- or IL-15-stimulated PBMCs isolated from patients with SLE","author":"Tur","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.humimm.2026.112039_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12884","article-title":"Serum levels of soluble programmed death-1 and soluble programmed death ligand 1 in systemic lupus erythematosus","volume":"92","author":"Du","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.humimm.2026.112039_bb0075","first-page":"78","article-title":"Elevated soluble Tim-3 correlates with disease activity of systemic lupus erythematosus","volume":"54","author":"Sun","year":"2021","journal-title":"Autoimmunity"},{"key":"10.1016\/j.humimm.2026.112039_bb0080","first-page":"603","article-title":"Serum levels of T cell immunoglobulin and mucin-domain containing molecule 3 in patients with systemic lupus erythematosus","volume":"31","author":"Atif","year":"2021","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.humimm.2026.112039_bb0085","article-title":"Soluble checkpoint molecules as predictive biomarkers for disease activity and long-term outcome in SLE","volume":"11","author":"Schrezenmeier","year":"2025","journal-title":"RMD Open"},{"key":"10.1016\/j.humimm.2026.112039_bb0090","article-title":"Identification and immunoassay of biomarkers associated with T cell exhaustion in systemic lupus erythematosus","volume":"16","author":"Zheng","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.112039_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1279","article-title":"Autoantibodies against complement component C1q in systemic lupus erythematosus","volume":"10","author":"Trendelenburg","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.humimm.2026.112039_bb0100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.192.3.359","article-title":"A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo","volume":"192","author":"Taylor","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2026.112039_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0065-2776(01)76021-X","article-title":"Systemic lupus erythematosus, complement deficiency, and apoptosis","volume":"76","author":"Pickering","year":"2000","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2026.112039_bb0110","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2174355","article-title":"Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients","volume":"45","author":"Liu","year":"2023","journal-title":"Ren. Fail."},{"key":"10.1016\/j.humimm.2026.112039_bb0115","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 EULAR\/ACR classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.humimm.2026.112039_bb0120","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2026.112039_bb0125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3758\/BRM.40.3.879","article-title":"Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models","volume":"40","author":"Preacher","year":"2008","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.humimm.2026.112039_bb0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Rosario","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.humimm.2026.112039_bb0135","first-page":"1234","article-title":"Comparison of methods for developing composite biomarker scores: application to the diagnosis of active SLE","volume":"31","author":"Tzeng","year":"2022","journal-title":"Lupus"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019888592600385X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019888592600385X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:36:57Z","timestamp":1790152617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019888592600385X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S019888592600385X"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112039","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum sPD-1 and sTIM-3 as T-cell exhaustion biomarkers in systemic lupus erythematosus: The IL-6-associated exhaustion axis and the SLE Immune Exhaustion Index","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112039"}}